Q4 2017 13F Holders as of 12/31/2017
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
334M
-
Number of holders
-
84
-
Total 13F shares, excl. options
-
57.6M
-
Shares change
-
+1.84M
-
Total reported value, excl. options
-
$461M
-
Value change
-
+$15.9M
-
Put/Call ratio
-
0.51
-
Number of buys
-
43
-
Number of sells
-
-35
-
Price
-
$8.00
Significant Holders of IOVANCE BIOTHERAPEUTICS, INC. - Common Stock (IOVA) as of Q4 2017
106 filings reported holding IOVA - IOVANCE BIOTHERAPEUTICS, INC. - Common Stock as of Q4 2017.
IOVANCE BIOTHERAPEUTICS, INC. - Common Stock (IOVA) has 84 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 57.6M shares
of 334M outstanding shares and own 17.24% of the company stock.
Largest 10 shareholders include ORBIMED ADVISORS LLC (5.55M shares), venBio Select Advisor LLC (5.25M shares), FRANKLIN RESOURCES INC (4.98M shares), BlackRock Inc. (4.86M shares), PERCEPTIVE ADVISORS LLC (4.78M shares), ACUTA CAPITAL PARTNERS, LLC (3.89M shares), Vanguard Group Inc (2.75M shares), Broadfin Capital, LLC (2.34M shares), FRAZIER MANAGEMENT LLC (2.19M shares), and VICTORY CAPITAL MANAGEMENT INC (2.1M shares).
This table shows the top 84 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.